Vladimir Sytnyk

11PUBLICATIONS
13CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Neurology and neuromuscular diseasesStructure and dynamics of materialsCellular nervous systemCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 18, 2025
CRISPRi screening in cultured human astrocytes uncovers distal enhancers controlling genes dysregulated in Alzheimer's disease.

Nicole F O Green, Gavin J Sutton, Javier Pérez-Burillo

|Nov 24, 2025
Region-specific variations in the cerebrovasculature underlie disease progression in Parkinson's disease.

Derya Dik, Glenda M Halliday, Vladimir Sytnyk

|Jul 25, 2025
The Reciprocal Relationship Between Cell Adhesion Molecules and Reactive Oxygen Species.

Muayad Al-Hadi, Alexander G Nikonenko, Vladimir Sytnyk

|Dec 15, 2024
Neuronal growth regulator 1 (NEGR1) promotes the synaptic targeting of glutamic acid decarboxylase 65 (GAD65).

Feifei Su, Grant Pfundstein, Saroj Sah

|Dec 16, 2023
'10th cell architecture in development and disease (CADD)': Meeting report.

Thomas Fath, Vladimir Sytnyk, Ramón Martínez-Mármol

|Jul 31, 2023
Deficiency in the neural cell adhesion molecule 2 (NCAM2) reduces axonal levels of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), affects axonal organization in the hippocampus, and leads to behavioral deficits.

Saroj Sah, Ryan Keable, Grant Pfundstein

Pageof 2

Frequent Collaborators

2 joint publications

Glenda M Halliday

1 joint publications

Saroj Sah

1 joint publications

Thomas Fath

1 joint publications

Ramón Martínez-Mármol